Mutations in the Estrogen Receptor Ligand Binding Domain Discriminate between Hormone-dependent Transactivation and Transrepression
Open Access
- 1 August 2000
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 275 (33) , 25322-25329
- https://doi.org/10.1074/jbc.m002497200
Abstract
No abstract availableKeywords
This publication has 70 references indexed in Scilit:
- Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonistThe EMBO Journal, 1999
- Recruitment of CBP/p300 by the IFNβ Enhanceosome Is Required for Synergistic Activation of TranscriptionMolecular Cell, 1998
- Distinct Domains of the RelA NF-κB Subunit Are Required for Negative Cross-talk and Direct Interaction with the Glucocorticoid ReceptorPublished by Elsevier ,1997
- Estrogen Receptors α and β Form Heterodimers on DNAJournal of Biological Chemistry, 1997
- ERβ: Identification and characterization of a novel human estrogen receptorFEBS Letters, 1996
- Cloning of a novel receptor expressed in rat prostate and ovary.Proceedings of the National Academy of Sciences, 1996
- A CBP Integrator Complex Mediates Transcriptional Activation and AP-1 Inhibition by Nuclear ReceptorsCell, 1996
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996
- Sequence and Characterization of a Coactivator for the Steroid Hormone Receptor SuperfamilyScience, 1995
- 17 beta-Estradiol inhibits expression of human interleukin-6 promoter-reporter constructs by a receptor-dependent mechanism.Journal of Clinical Investigation, 1994